|
JULY'S BEST FEATURED EDITORIAL |
|
|
|
On Business of Biotech, Al Sandrock, M.D., Ph.D., CEO of Voyager Therapeutics, explores tau as a key Alzheimer’s target and how gene therapy delivery could transform treatment at scale. |
|
|
JULY'S BEST INDUSTRY INSIGHTS |
|
|
|
|
|
| Connect With Life Science Leader: |
|
|
|